PTCT
#1229
PTC Therapeutics, Inc. - Common Stock
71.8 1 USD
-0.01%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-1.21%
Changement Mensuel
-4.06%
Evolution sur 6 mois
+7.05%
Changement Annuel
+44.14%
Clôture Précédente
72.6 9
Open
71.8 1
Low
71.8 1
High
71.8 1
Volume
77
Financials
- Market Capitalization 5.99 B
- Employee 991
- Founded 1998
- CEO Matthew B. Klein
- Website www.ptcbio.com
- Headquarter Delaware, United States
- FIGI BBG000QT15P7
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
9.76
ratio cours/chiffre d'affaires
3.88
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1209 |  BLTE Belite Bio Inc - American Depositary Shares | 157.01 USD | +0.20% | -3.97% | +2.48% | +146.10% | 6.18 B USD | ||
| 1228 |  XENE Xenon Pharmaceuticals Inc. - Common Shares | 61.93 USD | -2.92% | +2.45% | -5.19% | +51.83% | 6.00 B USD | ||
| 1245 |  DFTX Definium Therapeutics, Inc. - Common Shares | 43.82 USD | +0.11% | -4.51% | +4.33% | +190.01% | 5.89 B USD | ||
| 1261 |  CRSP CRISPR Therapeutics AG - Common Shares | 59.37 USD | +0.24% | -0.59% | +25.20% | +12.08% | 5.74 B USD |